SequelSEC

BIO-PATH HOLDINGS, INC. BPTH

Pharmaceutical Preparations · CIK 0001133818 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2018-12-31
Operating income
Unavailable
Fiscal year ended 2018-12-31
Free cash flow
Unavailable
Fiscal year ended 2018-12-31

This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BIO-PATH HOLDINGS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

BIO-PATH HOLDINGS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
RevenueUnavailable$37.00K$0$0$0$13.00K$0$0$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailable-$2.17M-$2.48M-$2.32M-$2.00M-$1.67M-$2.99M-$1.94M-$1.87M-$1.46M
Net incomeUnavailable-$2.17M-$2.47M-$1.98M-$397.00K-$1.37M-$1.57M-$1.94M-$1.87M-$1.46M
Research & developmentUnavailable$1.39M$1.58M$1.48M$1.03M$954.00K$2.31M$1.19M$1.02M$871.00K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailable$815.00K$893.00K$845.00K$970.00K$727.00K$681.00K$757.00K$849.00K$592.00K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

BIO-PATH HOLDINGS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$2.54M$8.86M$7.32M$9.43M$10.11M$12.20M$13.44M$7.14M$8.95M$10.76M
Current assets$2.14M$7.44M$5.79M$7.78M$8.35M$10.65M$12.41M$6.08M$7.83M$9.59M
Total liabilities$1.33M$791.00K$767.00K$576.00K$2.02M$3.96M$4.06M$813.00K$900.00K$937.00K
Current liabilities$1.33M$791.00K$767.00K$576.00K$709.00K$1.05M$866.00K$813.00K$900.00K$937.00K
Total equity incl. NCI$1.22M$8.07M$6.55M$8.86M$8.09M$8.24M$9.38M$6.33M$8.05M$9.82M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0
Accounts payable$587.00K$52.00K$121.00K$96.00K$89.00K$69.00K$118.00K$123.00K$201.00K$54.00K

Cash flow

BIO-PATH HOLDINGS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Operating cash flowUnavailable-$2.22M-$1.53M-$2.36M-$1.84M-$1.61MUnavailableUnavailableUnavailableUnavailable
Capital expendituresUnavailable$0$0$114.00K$424.00K$313.00K$25.00K$0$0$0
Investing cash flowUnavailable$0$0-$114.00K-$424.00K-$313.00KUnavailableUnavailableUnavailableUnavailable
Financing cash flowUnavailable$3.57M-$30.00KUnavailableUnavailable$0UnavailableUnavailableUnavailableUnavailable
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensationUnavailable$118.00K$168.00K$258.00K$249.00K$234.00K$232.00K$223.00K$95.00K$86.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

BIO-PATH HOLDINGS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2018-12-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Free cash flowUnavailable-$2.22M-$1.53M-$2.48M-$2.26M-$1.92MUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailable-5862.2%UnavailableUnavailableUnavailable-12830.8%UnavailableUnavailableUnavailableUnavailable
FCF marginUnavailable-6013.5%UnavailableUnavailableUnavailable-14800.0%UnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailable318.9%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio1.61x9.40x7.54x13.52x11.78x10.15x14.33x7.48x8.70x10.24x
Revenue YoY growthUnavailable184.6%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailable-5856.8%UnavailableUnavailableUnavailable-10546.2%UnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailable3759.5%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailable0.0%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BPTH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-20View SEC filing
10-Q · Filed 2026-01-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-03-27View SEC filing
10-Q · Filed 2024-11-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.